Through measurements of inflammatory gene expression levels and cytokine levels in patients P1 and P2, we found that the TLR7/9 and downstream type I IFN pathway were most significantly activated in DCs, suggesting that PLD4 deficiency in DCs triggers systemic inflammation and autoimmunity in patients. Here, PLD4 is linked to Autoimmunity.